PROTAC BRD2/BRD4 degrader 1 | Interleukin Related interleukin-related.com

Product Name :
PROTAC BRD2/BRD4 degrader 1

Search keywords :
PROTAC BRD2/BRD4 degrader-1

drugId :
null

Target Vo:
Bromodomain-containing protein 2

Target Vo Short Name :
BRD2

Moa_Name:
Bromodomain-containing protein 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
China Pharmaceutical University

Active Company_Name :
China Pharmaceutical University

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cy3-conjugated AffiniPure Goat Anti-Mouse IgG H&L
HMGB1 Antibody
SLC40A1 Antibody: SLC40A1 Antibody is an unconjugated, approximately 63 kDa, rabbit-derived, anti-SLC40A1 polyclonal antibody. SLC40A1 Antibody can be used for: WB, ELISA expriments in human, and predicted: mouse, rat, dog, pig, rabbit background without labeling.

Author: Interleukin Related

Related Posts